BEAM
Price
$25.38
Change
+$0.68 (+2.75%)
Updated
Jan 3 closing price
58 days until earnings call
MIST
Price
$2.20
Change
+$0.03 (+1.38%)
Updated
Jan 3 closing price
86 days until earnings call
Ad is loading...

BEAM vs MIST

Header iconBEAM vs MIST Comparison
Open Charts BEAM vs MISTBanner chart's image
Beam Therapeutics
Price$25.38
Change+$0.68 (+2.75%)
Volume$892.49K
CapitalizationN/A
Milestone Pharmaceuticals
Price$2.20
Change+$0.03 (+1.38%)
Volume$716.01K
CapitalizationN/A
BEAM vs MIST Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. MIST commentary
Jan 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and MIST is a Buy.

Ad is loading...
COMPARISON
Comparison
Jan 05, 2025
Stock price -- (BEAM: $25.38 vs. MIST: $2.20)
Brand notoriety: BEAM and MIST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 76% vs. MIST: 135%
Market capitalization -- BEAM: $2.1B vs. MIST: $117.32M
BEAM [@Biotechnology] is valued at $2.1B. MIST’s [@Biotechnology] market capitalization is $117.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileMIST’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • MIST’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than MIST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while MIST’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 4 bearish.
  • MIST’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MIST is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -4.55% price change this week, while MIST (@Biotechnology) price change was +2.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.67%. For the same industry, the average monthly price growth was +2.46%, and the average quarterly price growth was +10.80%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

MIST is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (+5.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.1B) has a higher market cap than MIST($117M). BEAM YTD gains are higher at: 2.339 vs. MIST (-6.780). MIST has higher annual earnings (EBITDA): -39.14M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. MIST (76.4M). MIST has less debt than BEAM: MIST (54M) vs BEAM (162M). BEAM has higher revenues than MIST: BEAM (350M) vs MIST (0).
BEAMMISTBEAM / MIST
Capitalization2.1B117M1,797%
EBITDA-160.83M-39.14M411%
Gain YTD2.339-6.780-34%
P/E RatioN/AN/A-
Revenue350M0-
Total Cash926M76.4M1,212%
Total Debt162M54M300%
TECHNICAL ANALYSIS
Technical Analysis
BEAMMIST
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 21 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA410.4431.16
+8.22%
Tesla
GME31.650.99
+3.23%
GameStop Corp
SPY591.957.31
+1.25%
SPDR® S&P 500® ETF Trust
BTC.X98236.230000128.796880
+0.13%
Bitcoin cryptocurrency
AAPL243.36-0.49
-0.20%
Apple

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.75%
CRSP - BEAM
71%
Closely correlated
-0.99%
DNLI - BEAM
64%
Loosely correlated
+2.02%
NTLA - BEAM
64%
Loosely correlated
-0.74%
PRME - BEAM
61%
Loosely correlated
+12.04%
RXRX - BEAM
59%
Loosely correlated
+8.18%
More

MIST and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIST has been loosely correlated with KRYS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MIST jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
+1.38%
KRYS - MIST
40%
Loosely correlated
+1.17%
CLDX - MIST
37%
Loosely correlated
+3.96%
MLTX - MIST
35%
Loosely correlated
-0.22%
BEAM - MIST
34%
Loosely correlated
+2.75%
INZY - MIST
31%
Poorly correlated
+7.72%
More